Tumor necrosis factor alpha delivers exogenous inflammation-related microRNAs to recipient cells with functional targeting capabilities07/2022 Journal: Molecular Therapy Author: Zhao, Y., Zhang, T., Shen, X., et al.
A Class of Shark-Derived Single-Domain Antibodies can Broadly Neutralize SARS-Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape05/2022 Journal: Small Method Author: Feng, B., Chen, Z., Sun, J., et al.
An automated, rapid fluorescent immunoassay to quantify serum soluble programmed death-1 (PD-1) protein using testing-on-a-probe biosensors05/2022 Journal: Clinical Chemistry and Laboratory Medicine Author: Zhang, J., Chen, L., Xu, Q., et al.
Development of a rapid neutralizing antibody test for SARS-CoV-2 and its application for neutralizing antibody screening and vaccinated serum testing04/2022 Journal: Infectious Medicine Author: Li, Y., Wang, M., Wu, H., et al.
Measurements of SARS-CoV-2 antibody dissociation rate constant by chaotrope-free biolayer interferometry in serum of COVID-19 convalescent patients03/2022 Journal: Biosensors and Bioelectronics Author: Hao, Y., Yang, H., Karbaschi, M., et al.
First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants03/2022 Journal: Clinica Chimica Author: Titong, A., Gallolu Kankanamalage, S., Dong, J. et al.
Reconstitution of purified membrane protein dimers in lipid nanodiscs with defined stoichiometry and orientation using a split GFP tether01/2022 Journal: JBC Author: Bruguera, E., Mahoney, J., Weis, W., et al.
Predicting Mutational Effects on Receptor Binding of the Spike Protein of SARS-CoV-2 Variants10/2021 Journal: Journal of the American Chemical Society Author: Bai, C., Wang, J., Chen, G., et al.
TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability09/2021 Journal: Clinical Chemistry Author: Racine-Brzostek, S., Karbaschi, M., Gaebler, C., et al.
Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination06/2021 Journal: Emerging Microbes & Infections Author: Chen, Y., Zhu, L., Huang, W., et al.
Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients05/2021 Journal: Virologica Sinica Author: Li, J., He, L., Deng, Y., et al.
A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients04/2021 Journal: JCM Author: Luo, R., Yun, C., Chakraborty, I., et al.
A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters09/2020 Journal: Frontiers in Immunology Author: Fagre, A. C., Manhard, J., Adams, R., et al.